A team of researchers from the University of Exeter has developed an innovative tool to help identify the most effective

The prion program utilizes Apertura's preclinical development data with an AAV capsid targeting human Transferrin Receptor 1 (TfR1) to provide

Small hometown fundraiser turned global movement for rare disease to be held across 21+ locations worldwide WELLESLEY, Mass., Feb. 28,

-- Oral presentation to highlight Phase 2a Part A results of the randomized, placebo-controlled SIGNAL-AA clinical trial evaluating bempikibart in

NEW YORK, Feb. 28, 2025 /PRNewswire/ -- MedComms Experts ("MCE" or the "Company"), a global provider of rare-disease-focused medical communications

Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS

… an environmentally destructive mode of agricultural production – the longer the livestock … basis for a more

The space industry thrives on precision, innovation and scientific rigor. But in today’s media landscape, facts often take a backseat

On February 19, the Mitchell Institute published a report on the United States Space Force’s Theory of Competitive Endurance. The

Two spacecraft, one from a startup and the other built by a major aerospace company, are experiencing problems after their